As noted in previous studies of the TME, IL-6 trans-signaling promotes the interaction between GP130, soluble IL-6 receptor (sIL-6R), and IL-6, driving JAK-STAT-dependent tumor cell migration. The gene discussed is IL6; the disease is neoplasm.